GAL3ST3
From Wikipedia, the free encyclopedia
Galactose-3-O-sulfotransferase 3
|
||
Identifiers | ||
Symbol(s) | GAL3ST3; GAL3ST2; GAL3ST-3; MGC142112; MGC142114 | |
External IDs | OMIM: 608234 MGI: 3617843 HomoloGene: 57198 | |
Orthologs | ||
Human | Mouse | |
Entrez | 89792 | 545276 |
Ensembl | ENSG00000175229 | ENSMUSG00000047658 |
Uniprot | Q96A11 | P61315 |
Refseq | NM_033036 (mRNA) NP_149025 (protein) |
XM_975776 (mRNA) XP_980870 (protein) |
Location | Chr 11: 65.57 - 65.57 Mb | Chr 19: 5.3 - 5.31 Mb |
Pubmed search | [1] | [2] |
Galactose-3-O-sulfotransferase 3, also known as GAL3ST3, is a human gene.[1]
This gene encodes a member of the galactose-3-O-sulfotransferase protein family. The product of this gene catalyzes sulfonation by transferring a sulfate group to the 3' position of galactose in N-acetyllactosamine in both type 2 (Gal-beta-1-4GlcNAc-R) oligosaccharides and core-2-branched O-glycans, but not on type 1 or core-1-branched structures. This gene, which has also been referred to as GAL3ST2, is different from the GAL3ST2 gene located on chromosome 2 that encodes a related enzyme with distinct tissue distribution and substrate specificities, compared to galactose-3-O-sulfotransferase 3.[1]
[edit] References
[edit] Further reading
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121-7. doi: . PMID 15489334.
- Chandrasekaran EV, Lakhaman SS, Chawda R, et al. (2004). "Identification of physiologically relevant substrates for cloned Gal: 3-O-sulfotransferases (Gal3STs): distinct high affinity of Gal3ST-2 and LS180 sulfotransferase for the globo H backbone, Gal3ST-3 for N-glycan multiterminal Galbeta1, 4GlcNAcbeta units and 6-sulfoGalbeta1, 4GlcNAcbeta, and Gal3ST-4 for the mucin core-2 trisaccharide.". J. Biol. Chem. 279 (11): 10032-41. doi: . PMID 14701868.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi: . PMID 12477932.
- El-Fasakhany FM, Uchimura K, Kannagi R, Muramatsu T (2001). "A novel human Gal-3-O-sulfotransferase: molecular cloning, characterization, and its implications in biosynthesis of (SO(4)-3)Galbeta1-4(Fucalpha1-3)GlcNAc.". J. Biol. Chem. 276 (29): 26988-94. doi: . PMID 11356829.
- Seko A, Hara-Kuge S, Yamashita K (2001). "Molecular cloning and characterization of a novel human galactose 3-O-sulfotransferase that transfers sulfate to gal beta 1-->3galNAc residue in O-glycans.". J. Biol. Chem. 276 (28): 25697-704. doi: . PMID 11333265.
- Suzuki A, Hiraoka N, Suzuki M, et al. (2001). "Molecular cloning and expression of a novel human beta-Gal-3-O-sulfotransferase that acts preferentially on N-acetyllactosamine in N- and O-glycans.". J. Biol. Chem. 276 (26): 24388-95. doi: . PMID 11323440.
- Chandrasekaran EV, Jain RK, Rhodes JM, et al. (2000). "Characterization of distinct Gal:3-O-sulfotransferase activities in human tumor epithelial cell lines and of calf lymph node GlcNAc : 6-O-sulfotransferase activity.". Glycoconj. J. 16 (9): 523-36. PMID 10815989.
- Bonaldo MF, Lennon G, Soares MB (1997). "Normalization and subtraction: two approaches to facilitate gene discovery.". Genome Res. 6 (9): 791-806. PMID 8889548.